Home
Product
Antibody
Biosimilar Antibodies
IL1RL2 (Recibokibart Biosimilar) Recombinant Monoclonal Antibody

IL1RL2 (Recibokibart Biosimilar) Recombinant Monoclonal Antibody

Code: CSB-RA888016MB1HU

Rate （N/A）
Review （0）

Size:

100ug

100ug500ug1mg5mg10mg50mg100mg200mg

US$199

Quantity:

Species Reactivity: Human

Send an Inquiry

Start an on-line Chat

Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Uniprot NO.

Q9HB29

Alternative Names

HB0034 research-grade biosimilar; HB 0034 research-grade biosimilar; Recombinant humanized anti-interleukin 36R monoclonal antibody(Huaota Biopharma) research-grade biosimilar ;IL1RL2 antibody; IL1RRP2 antibody; Interleukin-1 receptor-like 2 antibody; EC 3.2.2.6 antibody; IL-36 receptor antibody; IL-36R antibody; Interleukin-1 receptor-related protein 2 antibody; IL-1Rrp2 antibody; IL1R-rp2 antibody

Species Reactivity

Human

Immunogen

Recombinant Human IL1RL2 protein

Conjugate

Non-conjugated

Clonality

Monoclonal

Buffer

0.01M PBS，pH7.4

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Notes

Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.

Lead Time

3-4 weeks
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.

Concentration

It differs from different batches. Please contact us to confirm it.

Usage

It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

Datasheet & COA

Antibody FAQs

Description

This recombinant monoclonal antibody is developed as a research-grade biosimilar to Recibokibart, targeting IL1RL2 (Interleukin 1 Receptor Like 2), also known as IL-36R. IL1RL2 functions as a receptor for IL-36 cytokines, playing a critical role in innate immune responses and inflammatory signaling pathways. Upon ligand binding, IL1RL2 activates downstream NF-κB and MAPK signaling cascades, promoting the production of pro-inflammatory mediators. This receptor is implicated in various inflammatory and autoimmune conditions, including psoriasis, inflammatory bowel disease, and other skin disorders characterized by excessive keratinocyte activation and neutrophil recruitment.

Recibokibart represents a therapeutic antibody designed to block IL-36 receptor signaling, offering potential intervention in IL-36-mediated inflammatory diseases. This biosimilar antibody provides researchers with a valuable tool for investigating IL1RL2 biology, studying IL-36 signaling mechanisms, and exploring therapeutic strategies for inflammatory conditions. It supports studies examining cytokine-receptor interactions, immune cell activation, and disease pathogenesis in relevant experimental models.

Customer Reviews and Q&A

■ Customer Reviews

Submit a Review here

Target Background

Function(From Uniprot)

Receptor for interleukin-36 (IL36A, IL36B and IL36G). After binding to interleukin-36 associates with the coreceptor IL1RAP to form the interleukin-36 receptor complex which mediates interleukin-36-dependent activation of NF-kappa-B, MAPK and other pathways. The IL-36 signaling system is thought to be present in epithelial barriers and to take part in local inflammatory response; it is similar to the IL-1 system. Seems to be involved in skin inflammatory response by induction of the IL-23/IL-17/IL-22 pathway.

Gene References into Functions

Endothelial cells, including dermal microvascular cells, express a functionally active IL-36 receptor. PMID:27673278
All human blood lymphocytes express IL-36R. PMID:27269181
The data identify a novel role for IL-36 signaling in colonic inflammation and indicate that the IL-36R pathway may represent a novel target for therapeutic intervention. PMID:26813344
single nucleotide polymorphism A471T in the Toll-interleukin 1 receptor domain (TIR) of the IL-1Rrp2 that is present in approximately 2% of the human population, down-regulated IL-36R signaling by a decrease of interaction with IL-1RAcP. PMID:27307043
The IL36 receptor (IL1RL2) is an important mediator molecule in the inflammatory response. PMID:27853811
The ubiquitin-binding Tollip protein contributed to IL-36R signaling and increased the accumulation of both subunits of the IL-36R. PMID:26269592
IL36A-IL36R axis is modulated in patients with primary Sjogren's syndrome. PMID:25902739
Expression of IL-1Rrp2 by sone dendritic cell subsets may have an important function in the human immune response in vivo via its role in differentiation of inflammatory Th1 lymphocytes. PMID:22144259
These data provide evidence that IL-38 binds to the IL-36R, as does IL-36Ra.[IL-38, IL-36R] PMID:22315422
IL-1alpha and IL-1beta gene polymorphisms do not act as a strong susceptibility factor for MTLE-HS in individuals of Turkish ancestry PMID:16546408

Hide All

Subcellular Location

Membrane; Single-pass type I membrane protein.

Protein Families

Interleukin-1 receptor family

Tissue Specificity

Expressed in synovial fibroblasts and articular chondrocytes. Expressed in keratinocytes and monocyte-derived dendritic cells. Expressed in monocytes and myeloid dendritic cells; at protein level.

Database Links

HGNC: 5999

UNIGENE: Hs.659863

KEGG: hsa:8808

STRING: 9606.ENSP00000264257

OMIM: 604512

Promotions